缺血修饰白蛋白与急性心肌缺血的研究进展  

Research Progress in Acute Cardiac Ischemia and Ischemia-modified Albumin

作　　者：贾政[1] 古莉华[2] 魏玲[1] 

机构地区：[1]成都军区昆明总医院地方干部病房,昆明650032 [2]桂林医学院附属医院医保科,广西桂林541004

出　　处：《医学综述》2015年第2期219-221,共3页Medical Recapitulate

摘　　要：心肌缺血是引起一组连续进展性心血管疾病(如急性冠状动脉综合征)的最常见原因,现有的心肌生化标志物(如心肌酶谱等)只能在不可逆性心肌细胞损害时被检测出,而心肌缺血短期发作或可逆性发作时,此类标志物并不会明显升高。缺血修饰白蛋白是近年来被予以高度关注的反映早期心肌缺血的生物标志物,反应性灵敏,可辅助心肌缺血的早期诊断,以便早期临床干预。Cardiac ischemia is the most common cause of consecutive and aggressive cardiovascular diseases,such as acute coronary syndrome. The biomarkers,such as myocardial enzyme series,can be detectedonly when myocardial cells are damaged,while the expression of biomarkers in blood will not be significantly increased in situations of cardiac ischemia short-term attacks or reversible ischemic attack. Ischemia modified albumin is the biomarker highly concerned in recent years,which can reflect the myocardial ischemia condition earlier,which is sensitive enough to assist the early diagnosis of myocardial ischemia,so as to implement early clinical intervention.

关 键 词：心力衰竭 再灌注 心肌缺血 缺血修饰白蛋白 

分 类 号：R541.8[医药卫生—心血管疾病]